Pregled bibliografske jedinice broj: 598593
NT-proBNP in anthracycline-induced cardiotoxicity in children
NT-proBNP in anthracycline-induced cardiotoxicity in children // Biochemia Medica / Šimundić, Ana-Maria (ur.).
Zagreb, 2012. str. A62-A63 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 598593 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
NT-proBNP in anthracycline-induced cardiotoxicity in children
Autori
Grzunov, Ana ; Leniček Krleža, Jasna ; Obuljen, Jasna ; Žižić, Vesna ; Stepan-Giljević, Jasminka ; Kapitanović, Sanja
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Biochemia Medica
/ Šimundić, Ana-Maria - Zagreb, 2012, A62-A63
Skup
2nd European Joint Congress of EFLM and UEMS
Mjesto i datum
Dubrovnik, Hrvatska, 10.10.2012. - 13.10.2012
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
NT-proBNP; cardiotoxicity; child; tumors
Sažetak
Background: Anthracyclines (doxorubicin, daunorubicin and idarubicin) are highly efficacious antineoplastic agents for various malignances in children but their usefulness has been limited by cardiotoxicity causing cardiomyopathy and heart failure. The aim of this study was to assess the diagnostic accuracy of N-terminal-prohormone brain natriuretic peptide (NT-proBNP) in recognizing anthracycline related cardiotoxicity in children. Materials and methods: Serum levels of NT-proBNP were measured by electrochemiluminescence immunoassay (ECLIA) on the Cobas e 411 analyser (Roche Diagnostic, Mannheim, Germany. Results: We included 32 patients with median age of 15 years, who received anthracyclines in their chemotherapy. All patients had undergone cardiac evaluation that included electrocardiography and echocardiography. Toxicity was assessed according to the National Cancer Institute (NCI) Common toxicity criteria (version 2.0. With cut off of 125.0 pg/mL, sensitivity of NT-proBNP was 55.5% and specificity only 40.0%. The area under the receiver operating characteristic (ROC) curve was 0.548 (95% confidence interval (CI): 0.363-0.724) and odds ratio 0.83. Positive predictive value was 83.3 (95% CI: 58.6-96.4) and negative predictive value 14.3 (95%CI: 1.8-42.8). There was no statistical difference between serum NT-proBNP levels of the patients with normal and abnormal echocardiographic and electrocardiographic findings (P = 0.736. Conclusions: Due to specificity and sensitivity of NTproBNP, present study indicated that electrocardiographic and echocardiographic follow-up is more reliable than serum NT-proBNP levels for detecting cardiotoxicity. Further investigations in finding non-invasive and practical method for monitoring to identify cardiac damage at subclinical level are necessary.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
098-0982464-3120 - Farmakogenetika u dječjoj onkologiji (Stepan Giljević, Jasminka, MZOS ) ( CroRIS)
Ustanove:
Klinika za dječje bolesti Medicinskog fakulteta,
Institut "Ruđer Bošković", Zagreb
Profili:
Jasminka Stepan Giljević
(autor)
Vesna Žižić
(autor)
Sanja Kapitanović
(autor)
Jasna Leniček Krleža
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- MEDLINE